Screening methods for cervical cancer include Pap Smear for cytological detection of abnormal cells, HPV testing for high-risk strains like 16 and 18, and visual inspection techniques (VIA or VILI) suited for low-resource settings. Guidelines feature WHO-recommended screen-and-treat algorithms using VIA/HPV, along with FOGSI recommendations for HPV primary screening in women 30+ followed by cytological triage.
Screening Methods
| Screening Methods | Guidelines & Algorithms |
|---|
| • Pap Smear: Cytological detection of abnormal cervical cells
- HPV Testing: Identifies high-risk oncogenic strains (16,18)
- Visual Inspection: VIA (acetic acid) or VILI (iodine) for low-resource settings | • WHO-recommended: Screen-and-treat algorithms with VIA/HPV
- FOGSI Guidelines: HPV primary screening for women 30+, triage with cytology
📊 Medical icons: Microscope (Pap), DNA helix (HPV), Eye (Visual) |
Source: CIN Screening, Evaluation & Management Deep Dive
Speaker Notes
Highlight primary screening modalities: Pap smear for cytology, HPV DNA testing for high-risk types, and visual inspection with acetic acid (VIA). Reference WHO algorithms for low-resource settings and FOGSI guidelines for India.